J Korean Med Assoc.  2016 Apr;59(4):294-299. 10.5124/jkma.2016.59.4.294.

Management of long-term lung cancer survivors in Korea

• Shin J
• Zo JI
• Lee J

• KMID: 2161710
• DOI: http://doi.org/10.5124/jkma.2016.59.4.294

Abstract

Lung cancer survivors need to undergo continuous care by primary care physicians after acute treatment. The health problems of lung cancer survivors are associated with their treatment: for example, severe pain, respiratory difficulty, poor quality of life, or pneumonitis. They also have various comorbidities, such as stroke, myocardial infarction, arrhythmia, chronic obstructive pulmonary disease, or psychological problems. Surveillance of lung cancer survivors is based on an annual chest CT with routine physical examination. Incidence of second primary cancer in lung cancer survivors is reported to increase in the remnant lung, head and neck, kidney, bladder, thyroid, stomach, and breast. Therefore, lung cancer survivors need to undergo regular health examination for early detection of cancer. Smoking status, weight change, drinking behavior, and vaccination, especially influenza and pneumococcal vaccination, should be assessed whenever the patient meets a clinician. The primary care physician would be expected to take on the role of managing the health problems of Korean lung cancer survivors comprehensively, including physical and psychosocial problems, from screening to survivorship care.

Keyword

Lung neoplasms; Survivors; Long-term care; Primary health care

MeSH Terms

Arrhythmias, Cardiac
Breast
Comorbidity
Drinking Behavior
Early Detection of Cancer
Head
Humans
Incidence
Influenza, Human
Kidney
Korea*
Long-Term Care
Lung Neoplasms*
Lung*
Mass Screening
Myocardial Infarction
Neck
Neoplasms, Second Primary
Physical Examination
Physicians, Primary Care
Pneumonia
Primary Health Care
Pulmonary Disease, Chronic Obstructive
Quality of Life
Smoke
Smoking
Stomach
Stroke
Survival Rate
Survivors*
Thyroid Gland
Tomography, X-Ray Computed
Urinary Bladder
Vaccination
Smoke

Reference

1. Korea Central Cancer Registry. 2013 Statistics on cancer registry [Internet]. Goyang: National Cancer Center;2015. cited 2016 Mar 11. Available from: http://www.ncc.re.kr/cancerStatsList.ncc?searchKey=total&searchValue=&pageNum=1.

2. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47:127–141.

3. Health Insurance Review and Assessment Service. The 2nd assessment analysis of feasibility in lung cancer treatment [Internet]. Wonju: Health Insurance Review and Assessment Service;2016. cited 2016 Mar 11. Available from: http://www.hira.or.kr/dummy.do?pgmid=HIRAA020041000000.

4. Korean Association for the Study of Lung Cancer. 2010 Guidelines for lung cancer screening. Daejeon: Korean Associa-tion for the Study of Lung Cancer;2010.

5. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012; 144:33–38.

6. Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg. 2013; 145:75–81.

7. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998; 90:1335–1345.

8. Huang J, Logue AE, Ostroff JS, Park BJ, McCabe M, Jones DR, Bains MS, Rizk NP, Kris MG, Rusch VW. Comprehensive long-term care of patients with lung cancer: development of a novel thoracic survivorship program. Ann Thorac Surg. 2014; 98:955–961.

9. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan A, Smythe WR, Swisher S, Walsh G, Putnam JB Jr, Hong WK, Roth J. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003; 76:1001–1007.

10. Tabuchi T, Ito Y, Ioka A, Miyashiro I, Tsukuma H. Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data. Cancer Sci. 2012; 103:1111–1120.

11. Danson SJ, Rowland C, Rowe R, Ellis S, Crabtree C, Horsman JM, Wadsley J, Hatton MQ, Woll PJ, Eiser C. The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study. Support Care Cancer. 2016; 24:1507–1516.

12. Yun YH, Kim YA, Min YH, Chang YJ, Lee J, Kim MS, Lee HS, Kim J, Choi YS, Shim YM, Zo JI. Health-related quality of life in disease-free survivors of surgically treated lung cancer compared with the general population. Ann Surg. 2012; 255:1000–1007.

13. Seo HG, Park JH. Evidence-based cancer survivorship management. Goyang: National Cancer Center;2013.

14. Walsh JC, Low PA, Allsop JL. Localized sympathetic overacti-vity: an uncommon complication of lung cancer. J Neurol Neurosurg Psychiatry. 1976; 39:93–95.

15. Nishimura J, Tamada Y, Iwase S, Kubo A, Watanabe D, Matsu-moto Y. A case of lung cancer with unilateral anhidrosis and contralateral hyperhidrosis as the first clinical manifestation. J Am Acad Dermatol. 2011; 65:438–440.

16. Shargall Y, Spratt E, Zeldin RA. Hyperhidrosis: what is it and why does it occur. Thorac Surg Clin. 2008; 18:125–132.

17. Kravchenko J, Berry M, Arbeev K, Kim Lyerly H, Yashin A, Akushevich I. Cardiovascular comorbidities and survival of lung cancer patients: medicare data based analysis. Lung Cancer. 2015; 88:85–93.

18. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology. 2004; 62:2025–2030.

19. Navi BB, Reichman JS, Berlin D, Reiner AS, Panageas KS, Segal AZ, DeAngelis LM. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology. 2010; 74:494–501.

20. Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W, Stovall M, Chow EJ, Sklar CA, Mulrooney DA, Mertens AC, Border W, Durand JB, Robison LL, Meacham LR. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013; 31:3673–3680.

21. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003; 103:792–802.

22. Park JJ, Park HA. Prevalence of cigarette smoking among adult cancer survivors in Korea. Yonsei Med J. 2015; 56:556–562.

23. Kim H, Kim MH, Park YS, Shin JY, Song YM. Factors that predict persistent smoking of cancer survivors. J Korean Med Sci. 2015; 30:853–859.

24. Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, Lane AT, West M, Eves ND, Gradison M, Coan A, Herndon JE, Abernethy AP. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer. 2012; 76:248–252.

25. Peddle-McIntyre CJ, Bell G, Fenton D, McCargar L, Courneya KS. Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors. Lung Cancer. 2012; 75:126–132.

26. Kaptein AA, Kobayashi K, Matsuda A, Kubota K, Nagai S, Momiyama M, Sugisaki M, Bos BC, Warning TD, Dik H, Klink Rv, Inoue K, Ramai R, Taube C, Kroep JR, Fischer MJ. We're in this together: patients', caregivers' and health care providers' illness perceptions about non-small-cell lung cancer (NSCLC). Lung Cancer. 2015; 90:575–581.

27. Shen MJ, Hamann HA, Thomas AJ, Ostroff JS. Association between patient-provider communication and lung cancer stigma. Support Care Cancer. 2016; 24:2093–2099.

28. Stuber J, Galea S, Link BG. Smoking and the emergence of a stigmatized social status. Soc Sci Med. 2008; 67:420–430.

29. Cote ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeboller H, Boffetta P, Brennan P, Brenner H, Duell EJ, Fabianova E, Field JK, Foretova L, Friis S, Harris CC, Holcatova I, Hong YC, Isla D, Janout V, Kiemeney LA, Kiyohara C, Lan Q, Lazarus P, Lissowska J, Le Marchand L, Mates D, Matsuo K, Mayordomo JI, McLaughlin JR, Morgenstern H, Mueller H, Orlow I, Park BJ, Pinchev M, Raji OY, Rennert HS, Rudnai P, Seow A, Stucker I, Szeszenia-Dabrowska N, Dawn Teare M, Tjonnelan A, Ugolini D, van der Heijden HF, Wichmann E, Wiencke JK, Woll PJ, Yang P, Zaridze D, Zhang ZF, Etzel CJ, Hung RJ. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012; 48:1957–1968.